Results

Total Results: 801 records

Showing results for "described".

181. Recommendation: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-children-and-adolescents-screening
     June 18, 2024 - Most trials described the level of patient participation in interventions. … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

182. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
     April 15, 2013 - criteria for studies of benefits, harms, and subgroup outcomes (key questions 1 through 3) have been fully described … raloxifene for 2 outcomes (mortality and endometrial cancer for raloxifene) with new data using methods described … Surveys of Medication Decisions and Concordance Twelve studies described how women or physicians … Two other studies also described concerns about adverse effects 67 , 71 . … Four were rated as fair-quality because they inadequately described the population and follow-up 97 ,

183. PII: S0749-3797(01)00261-6 (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/Harris2001.pdf
     January 01, 2001 - RCTs Diagnostic accuracy studies ● Screening test relevant, available for primary care, adequately described … For example, the evidence for smoking cessation counseling could be described as grade I-good evidence … Evidence for an intervention is sometimes described as good if it shows a dramatic effect on outcomes … general confidence interval on the 4-point scale (e.g., substantial, moderate, small, and zero/negative) described

184. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
     May 18, 2021 - These comparisons are described in the JAMA Supplement and are highlighted in eTables 9 through 12 … assumptions about colorectal cancer incidence rates in the absence of screening, analyses for the USPSTF described … While the models described here have been extensively calibrated and validated, they are limited by uncertainty

185. Archived: Final Evidence Summary: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary4/colorectal-cancer-screening-2008
     October 15, 2008 - The performance of screening tests is preferentially described per person (sensitivity and specificity … These 3 categories generally map to the CT Colonography Report and Data System (C-RADS). 71 , as described … We therefore searched MEDLINE and the Cochrane Library from 1990, when these tests began to be described … The performance of screening tests is preferentially described per person (sensitivity and specificity … The model was described briefly as follows.

186. Screening for Anxiety in Children and Adolescents: US Preventive Services Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/qWZxPBqpffTYVNvGYPkohz
     May 01, 2021 - of lesbian, gay, bisexual, transgender, and queer youth and 77% of transgender and nonbi- nary youth described … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

187. Recommendation: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening
     February 25, 2020 - This trial and its limitations are described above. … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

188. Interventions for High Body Mass Index in Children and Adolescents: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kXAtzuxCxKJcHK9Fg63GA3
     April 01, 2023 - Most trials described the level of patient participation in interventions. … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described

189. Archived: Iron Deficiency Anemia in Pregnant Women: Screening and Supplementation | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/iron-deficiency-anemia-in-pregnant-women-screening-and-supplementation-september-2015
     September 07, 2015 - supplementation for the prevention of iron deficiency anemia; however, findings on iron deficiency are also described … Disclosures: Authors followed the policy regarding conflicts of interest described at http://www.uspreventiveservicestaskforce.org

190. Archived: Modeling Report: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/modeling-report/lung-cancer-screening-december-2013
     July 30, 2013 - Additionally, model results were compared using a formal approach previously described in the literature … close to or on the efficient frontier and were identified as consensus efficient using both approaches described

191. Screening for Syphilis Infection in Nonpregnant Adults: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/VhSwc46MPwjDPNsgVrVm-B
     June 07, 2016 - ethnic groups, and being a male younger than 29 years, as well as regional variations that are well described … Authors followed the policy regarding conflicts of interest described at http: //www.uspreventiveservicestaskforce.org

192. Archived: Skin Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening-july-2016
     July 26, 2016 - all skin cancer types, the evidence that met the prespecified inclusion criteria for the review only described … Authors followed the policy regarding conflicts of interest described at http://www.uspreventiveservicestaskforce.org

193. Screening for Syphilis: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
     July 01, 2004 - No studies were identified that specifically described the harms and costs of treatment. … an unselected pop, not relevant to primary care 8 Exclude Not an RCT 9 Exclude No health outcomes described

194. U.S. Preventive Services Task Force Approach to Child Cognitive and Behavioral Health (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstfchildhealth.pdf
     October 01, 2016 - As previously described, the USPSTF does not consider issues related to cost or coverage in developing

195. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R3y9LSud52CGL8mG4wvxoT
     June 09, 2020 - TheaggregatestrengthofevidencewasassessedforeachKQusing the approach described in the Agency for Healthcare … The intensity of coun- seling ranged from “minimal” (not described) to “standard” coun- seling for 45 … 14 in the Supplement).125,129-141 All patients in the trials received drug use counseling, usually described … Four trials described inpatient or residential withdrawal from opioids; details were otherwise not well … As described in the full report,8 evidence on the benefits and harms of preemptive prescribing of naloxone

196. 6Jfgjyjsbmc48Mj2Uksahb (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/6jFgJYJSbMc48mj2uKsAhB
     October 01, 2014 - The USPSTF previously described the challenges of developing behavioral counseling recommendations that … Authors followed the policy regarding conflicts of interest described at www.uspreventiveservicestask

197. Draft Research Plan: Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
     April 25, 2024 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Draft Research Plan Enhanced Risk Assessment for Cardiovascular Disease: Coronary Artery Calcium Scoring April 25, 2024 Recommendations made by the USPSTF are…

198. Final Research Plan: Sexually Transmitted Infections: Behavioral Counseling | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/sexually-transmitted-infections
     May 01, 2025 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Sexually Transmitted Infections: Behavioral Counseling May 01, 2025 Recommendations made by the USPSTF are independent of the U.S. gover…

199. Final Research Plan: Perinatal Depression: Preventive Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/perinatal-depression-interventions-to-prevent
     June 01, 2023 - Share to Facebook Share to X Share to WhatsApp Share to Email Print in progress Final Research Plan Perinatal Depression: Preventive Interventions June 01, 2023 Recommendations made by the USPSTF are independent of the U.S. government. T…

200. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/3HxQuXnyqHpUKNqjB7hWBw
     September 01, 2005 - Models with potential clinical applications (22–24, 57–72) are described in Table 2. … Surgical complications attributable to prophylactic oo- phorectomy are not well described and may vary … Screening test relevant, available for primary care, ade- quately described. 2. … Calculation of 95% CI for penetrance in equations 4 and 5 is similar to that described above, with appropriate